Drug Type Mesenchymal stem cell therapy |
Synonyms Umbilical Cord Mesenchymal Stem Cells(Huishan), HS_SW01 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Primary Ovarian Insufficiency | Phase 2 | - | 15 Apr 2026 | |
| Ankylosing Spondylitis | Phase 2 | - | 10 Apr 2026 | |
| Scleroderma, Diffuse | Phase 2 | - | 10 Apr 2026 | |
| Ovarian Insufficiency | Phase 1 | China | 11 Mar 2026 |





